Arginine/arginase no no no

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 26, Issue 2, 2006, Pages 237-239

  Getz, Godfrey S ^a   Reardon, Catherine A ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE; ARGININE; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE;

ATHEROGENESIS; DISEASE PREDISPOSITION; EDITORIAL; HYBRIDIZATION; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASODILATATION; ANIMAL; ATHEROSCLEROSIS; HUMAN; METABOLISM; NOTE;

ANIMALS; ARGINASE; ARGININE; ATHEROSCLEROSIS; HUMANS; NITRIC OXIDE;

EID: 33644859601     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000202014.54609.9d     Document Type: Editorial

References (22)

1. Morris SM Jr. Enzymes of arginine metabolism. J Nutr. 2004;134:2743S-2747S.
2. Teupser D, Burkhardt R, Wilfert W, Haffner I, Nebendahl K, Thiery J. Identification of macrophage arginase I as a new candidate gene of atherosclerosis resistance. Arterioscler Thromb Vasc Biol. 2006;26:365-371.
3. Boger RH, Bode-Boger SM. The clinical pharmacology of L-arginine. Annu Rev Pharmacol Toxicol. 2001;41:79-99.
4. Alderton WK, Cooper CE, Knowles RG. Nitric oxide synthases: structure, function and inhibition. Biochem J. 2001;357:593-615.
5. Cooke JP. Flow, NO, and atherogenesis. Proc Natl Acad Sci U S A. 2003;100:768-770.
6. Shaul PW. Endothelial nitric oxide synthase, caveolae and the development of atherosclerosis. J Physiol. 2003;547:21-33.
7. Landmesser U, Dikalov S, Price SR, McCann L, Fukai T, Holland SM, Mitch WE, Harrison DG. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest. 2003;111:1201-1209.
8. Munder M, Eichmann K, Modolell M. Alternative metabolic states in murine macrophages reflected by the nitric oxide synthase/arginase balance: competitive regulation by CD4+ T cells correlates with Th1/Th2 phenotype. J Immunol. 1998;160:5347-5354.
9. Wei LH, Jacobs AT, Morris SM Jr, Ignarro LJ. IL-4 and IL-13 upregulate arginase I expression by cAMP and JAK/STAT6 pathways in vascular smooth muscle cells. Am J Physiol Cell Physiol. 2000;279:C248-C256.
10. Munder M, Eichmann K, Moran JM, Centeno F, Soler G, Modolell M. Th1/Th2-regulated expression of arginase isoforms in murine macrophages and dendritic cells. J Immunol. 1999;163:3771-3777.
11. Wei LH, Wu G, Morris SM Jr, Ignarro LJ. Elevated arginase I expression in rat aortic smooth muscle cells increases cell proliferation. Proc Natl Acad Sci U S A. 2001;98:9260-9264.
12. Durante W, Liao L, Reyna SV, Peyton KJ, Schafer AI. Transforming growth factor-beta(1) stimulates L-arginine transport and metabolism in vascular smooth muscle cells: role in polyamine and collagen synthesis. Circulation. 2001;103:1121-1127.
13. Cheng JF, Printz R, Callaghan T, Shuey D, Hardison RC. The rabbit C family of short, interspersed repeats. Nucleotide sequence determination and transcriptional analysis. J Mol Biol. 1984;176:1-20.
14. Krane DE, Clark AG, Cheng JF, Hardison RC. Subfamily relationships and clustering of rabbit C repeats. Mol Biol Evol. 1991;8:1-30.
15. Kass DH, Kim J, Rao A, Deininger PL. Evolution of B2 repeats: the muroid explosion. Genetica. 1997;99:1-13.
16. Kass DH, Raynor ME, Williams TM. Evolutionary history of B1 retroposons in the genus Mus. J Mol Evol. 2000;51:256-264.
17. Pollock JS, Forstermann U, Mitchell JA, Warner TD, Schmidt HH, Nakane M, Murad F. Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells. Proc Natl Acad Sci U S A. 1991;88:10480-10484.
18. Loscalzo J. An experiment of nature: genetic L-arginine deficiency and NO insufficiency. J Clin Invest. 2001;108:663-664.
19. Lee J, Ryu H, Ferrante RJ, Morris SM Jr, Ratan RR. Translational control of inducible nitric oxide synthase expression by arginine can explain the arginine paradox. Proc Natl Acad Sci U S A. 2003;100:4843-4848.
20. Boger RH. Asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, explains the "L-arginine paradox" and acts as a novel cardiovascular risk factor. J Nutr. 2004;134:28428-28478.
21. Cooke JP. Asymmetrical dimethylarginine: the Uber marker? Circulation. 2004;109:1813-1818.
22. Morris SM Jr. Recent advances in arginine metabolism. Curr Opin Clin Nutr Metab Care. 2004;7:45-51.